位置:首页 > 蛋白库 > TRIB1_MOUSE
TRIB1_MOUSE
ID   TRIB1_MOUSE             Reviewed;         372 AA.
AC   Q8K4K4; Q8BFS7; Q8BJR9; Q8BZX3; Q91W04;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 2.
DT   03-AUG-2022, entry version 147.
DE   RecName: Full=Tribbles homolog 1;
DE            Short=TRB-1;
GN   Name=Trib1 {ECO:0000312|MGI:MGI:2443397};
GN   Synonyms=Trb1 {ECO:0000312|MGI:MGI:2443397};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=15299019; DOI=10.1074/jbc.m407732200;
RA   Kiss-Toth E., Bagstaff S.M., Sung H.Y., Jozsa V., Dempsey C., Caunt J.C.,
RA   Oxley K.M., Wyllie D.H., Polgar T., Harte M., O'Neill L.A.J.,
RA   Qwarnstrom E.E., Dower S.K.;
RT   "Human tribbles, a protein family controlling mitogen-activated protein
RT   kinase cascades.";
RL   J. Biol. Chem. 279:42703-42708(2004).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:BAC28245.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAC37854.1};
RC   TISSUE=Aorta {ECO:0000312|EMBL:BAC37854.1},
RC   Hypothalamus {ECO:0000312|EMBL:BAE37097.1},
RC   Lung {ECO:0000312|EMBL:BAC28245.1}, Skin {ECO:0000312|EMBL:BAC26038.1}, and
RC   Vein {ECO:0000312|EMBL:BAC37854.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAH06800.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=FVB/N-3 {ECO:0000312|EMBL:AAH06800.1};
RC   TISSUE=Mammary gland {ECO:0000312|EMBL:AAH06800.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION.
RX   PubMed=20410507; DOI=10.1182/blood-2009-07-229450;
RA   Dedhia P.H., Keeshan K., Uljon S., Xu L., Vega M.E., Shestova O.,
RA   Zaks-Zilberman M., Romany C., Blacklow S.C., Pear W.S.;
RT   "Differential ability of Tribbles family members to promote degradation of
RT   C/EBPalpha and induce acute myelogenous leukemia.";
RL   Blood 116:1321-1328(2010).
RN   [5]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=24003916; DOI=10.1111/dom.12151;
RA   Akira S., Misawa T., Satoh T., Saitoh T.;
RT   "Macrophages control innate inflammation.";
RL   Diabetes Obes. Metab. Suppl. 3:10-18(2013).
RN   [6]
RP   FUNCTION.
RX   PubMed=23515163; DOI=10.1038/nature11930;
RA   Satoh T., Kidoya H., Naito H., Yamamoto M., Takemura N., Nakagawa K.,
RA   Yoshioka Y., Morii E., Takakura N., Takeuchi O., Akira S.;
RT   "Critical role of Trib1 in differentiation of tissue-resident M2-like
RT   macrophages.";
RL   Nature 495:524-528(2013).
CC   -!- FUNCTION: Adapter protein involved in protein degradation by
CC       interacting with COP1 ubiquitin ligase (PubMed:23515163,
CC       PubMed:20410507). Promotes CEBPA degradation and inhibits its function
CC       (PubMed:20410507). Controls macrophage, eosinophil and neutrophil
CC       differentiation via the COP1-binding domain (PubMed:24003916,
CC       PubMed:23515163). Regulates myeloid cell differentiation by altering
CC       the expression of CEBPA in a COP1-dependent manner (PubMed:23515163).
CC       Interacts with MAPK kinases and regulates activation of MAP kinases,
CC       but has no kinase activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q96RU8, ECO:0000269|PubMed:20410507,
CC       ECO:0000269|PubMed:23515163, ECO:0000269|PubMed:24003916}.
CC   -!- SUBUNIT: Monomer. Interacts (via protein kinase domain) with CEBPA.
CC       Interacts with COP1. {ECO:0000250|UniProtKB:Q96RU8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:15299019};
CC         IsoId=Q8K4K4-1; Sequence=Displayed;
CC       Name=2 {ECO:0000305};
CC         IsoId=Q8K4K4-2; Sequence=VSP_051888;
CC   -!- DOMAIN: The COP1-binding motif (355-360) is required for regulation
CC       activity (PubMed:24003916). {ECO:0000269|PubMed:24003916}.
CC   -!- DOMAIN: The C-terminus (351-372) is required for interaction with COP1
CC       (By similarity). {ECO:0000250|UniProtKB:Q96RU8}.
CC   -!- DOMAIN: The protein kinase active site is incompatible with ATP binding
CC       and is inactive (By similarity). {ECO:0000250|UniProtKB:Q96RU8}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. Tribbles subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC28245.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC37854.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF358866; AAM45478.1; -; mRNA.
DR   EMBL; AK028626; BAC26038.1; -; mRNA.
DR   EMBL; AK033358; BAC28245.1; ALT_INIT; mRNA.
DR   EMBL; AK040738; BAC30688.1; -; mRNA.
DR   EMBL; AK041212; BAC30865.1; -; mRNA.
DR   EMBL; AK080228; BAC37854.1; ALT_INIT; mRNA.
DR   EMBL; AK162876; BAE37097.1; -; mRNA.
DR   EMBL; BC006800; AAH06800.1; -; mRNA.
DR   CCDS; CCDS27499.1; -. [Q8K4K4-1]
DR   RefSeq; NP_653132.1; NM_144549.4. [Q8K4K4-1]
DR   AlphaFoldDB; Q8K4K4; -.
DR   SMR; Q8K4K4; -.
DR   BioGRID; 229263; 3.
DR   IntAct; Q8K4K4; 1.
DR   STRING; 10090.ENSMUSP00000068834; -.
DR   iPTMnet; Q8K4K4; -.
DR   PhosphoSitePlus; Q8K4K4; -.
DR   PaxDb; Q8K4K4; -.
DR   PRIDE; Q8K4K4; -.
DR   ProteomicsDB; 259096; -. [Q8K4K4-1]
DR   ProteomicsDB; 259097; -. [Q8K4K4-2]
DR   Antibodypedia; 27210; 389 antibodies from 32 providers.
DR   DNASU; 211770; -.
DR   Ensembl; ENSMUST00000067543; ENSMUSP00000068834; ENSMUSG00000032501. [Q8K4K4-1]
DR   Ensembl; ENSMUST00000118228; ENSMUSP00000112828; ENSMUSG00000032501. [Q8K4K4-2]
DR   GeneID; 211770; -.
DR   KEGG; mmu:211770; -.
DR   UCSC; uc007vxw.1; mouse. [Q8K4K4-1]
DR   CTD; 10221; -.
DR   MGI; MGI:2443397; Trib1.
DR   VEuPathDB; HostDB:ENSMUSG00000032501; -.
DR   eggNOG; KOG0583; Eukaryota.
DR   GeneTree; ENSGT00950000182986; -.
DR   HOGENOM; CLU_000288_13_1_1; -.
DR   InParanoid; Q8K4K4; -.
DR   OMA; KEPWERL; -.
DR   OrthoDB; 1362510at2759; -.
DR   PhylomeDB; Q8K4K4; -.
DR   TreeFam; TF329785; -.
DR   BioGRID-ORCS; 211770; 4 hits in 77 CRISPR screens.
DR   ChiTaRS; Trib1; mouse.
DR   PRO; PR:Q8K4K4; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; Q8K4K4; protein.
DR   Bgee; ENSMUSG00000032501; Expressed in granulocyte and 178 other tissues.
DR   Genevisible; Q8K4K4; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0031434; F:mitogen-activated protein kinase kinase binding; ISO:MGI.
DR   GO; GO:0004860; F:protein kinase inhibitor activity; ISO:MGI.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IDA:BHF-UCL.
DR   GO; GO:0055106; F:ubiquitin-protein transferase regulator activity; IDA:BHF-UCL.
DR   GO; GO:0007254; P:JNK cascade; ISO:MGI.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0031665; P:negative regulation of lipopolysaccharide-mediated signaling pathway; ISO:MGI.
DR   GO; GO:0045659; P:negative regulation of neutrophil differentiation; IMP:CACAO.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; ISO:MGI.
DR   GO; GO:0014912; P:negative regulation of smooth muscle cell migration; ISO:MGI.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; ISO:MGI.
DR   GO; GO:0045645; P:positive regulation of eosinophil differentiation; IMP:CACAO.
DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; IMP:CACAO.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0051443; P:positive regulation of ubiquitin-protein transferase activity; IC:BHF-UCL.
DR   GO; GO:0043405; P:regulation of MAP kinase activity; ISS:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IMP:BHF-UCL.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR024105; TRB1.
DR   InterPro; IPR024104; Tribbles/Ser_Thr_kinase_40.
DR   PANTHER; PTHR22961; PTHR22961; 1.
DR   PANTHER; PTHR22961:SF17; PTHR22961:SF17; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Protein kinase inhibitor; Reference proteome.
FT   CHAIN           1..372
FT                   /note="Tribbles homolog 1"
FT                   /id="PRO_0000131860"
FT   DOMAIN          1..338
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          49..85
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           355..360
FT                   /note="COP1-binding"
FT                   /evidence="ECO:0000269|PubMed:24003916"
FT   COMPBIAS        59..73
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         219..372
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_051888"
FT   CONFLICT        224
FT                   /note="E -> G (in Ref. 1; AAM45478)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        278
FT                   /note="L -> W (in Ref. 1; AAM45478)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   372 AA;  41281 MW;  AD29BB4E640B4B62 CRC64;
     MRVGPVRFAL SGASQPRGPG LLFPAARGTP AKRLLDTDDA GAVAAKCPRL SECSSPPDYL
     SPPGSPCSPQ PPPSTQGTGG SCVSSPGPSR IADYLLLPLA EREHVSRALC IHTGRELRCK
     EFPIKHYQDK IRPYIQLPSH SNITGIVEVL LGESKAYVFF EKDFGDMHSY VRSRKRLREE
     EAARLFKQIV SAVAHCHQSA IVLGDLKLRK FVFSTEERTQ LRLESLEDTH IIKGEDDALS
     DKHGCPAYVS PEILNTTGTY SGKAADVWSL GVMLYTLLVG RYPFHDSDPS ALFSKIRRGQ
     FCIPEHVSPK ARCLIRSLLR REPSERLTAP QILLHPWFEY VLEPGYVDSE IGTSDQIVPE
     YQEDSDISSF FC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024